Chronic pain is common and often undertreated. Access to effective, nonpharmacologic therapies is limited, especially in low-income and ethnically diverse […]
The Formulary Management Expert Committee (FMEC) recommends that pertuzumab in combination with trastuzumab and chemotherapy be reimbursed for the treatment
Post Content
Traditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) is a pragmatic, randomized trial that primarily evaluates whether, in early
Tools that leverage machine learning, a subset of artificial intelligence, are becoming increasingly important for conducting evidence synthesis as the
Pharmacy plays a critical role in improving patient outcomes and strengthening health systems. In May 2025, the National Academies convened
The aims of this investigation are
The U.S. medicolegal death investigation system is responsible for investigating and providing determinations of cause and manner of death, playing
Post Content
Multiple sclerosis (MS) is a common cause of neurological disability among young and middle-aged people, most often with a relapsing-remitting
Registration No: 771800548 Contact Number : +91-8249516996
